Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Janneke Molkenboer-Kuenen"'
Autor:
Thorbald van Hall, Jim Middelburg, Gerwin Gerhard Wemke Sandker, Evienne Wilbrink, Janneke Molkenboer-Kuenen, Erik Aarntzen, Sandra Heskamp
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background CD3 bispecific antibodies (CD3-bsAbs) require binding of both a tumor-associated surface antigen and CD3 for their immunotherapeutic effect. Their efficacy is, therefore, influenced by the tumor uptake and the extracellular dose. To optimi
Externí odkaz:
https://doaj.org/article/a20cb64dfac3462d8468563a33246239
Autor:
Gerwin G. W. Sandker, Gosse Adema, Janneke Molkenboer-Kuenen, Peter Wierstra, Johan Bussink, Sandra Heskamp, Erik H. J. G. Aarntzen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundProgrammed death-ligand 1 (PD-L1) regulates immune homeostasis by promoting T-cell exhaustion. It is involved in chronic infections and tumor progression. Nuclear imaging using radiolabeled anti-PD-L1 antibodies can monitor PD-L1 tissue exp
Externí odkaz:
https://doaj.org/article/785887c64a7e45628531f9d9e709f550
Autor:
Robin M. de Kruijff, René Raavé, Annemarie Kip, Janneke Molkenboer-Kuenen, Stefan J. Roobol, Jeroen Essers, Sandra Heskamp, Antonia G. Denkova
Publikováno v:
Pharmaceutics, Vol 11, Iss 5, p 241 (2019)
The use of nanoparticles as tumor-targeting agents is steadily increasing, and the influence of nanoparticle characteristics such as size and stealthiness have been established for a large number of nanocarrier systems. However, not much is known abo
Externí odkaz:
https://doaj.org/article/2a3362d91cbc4dd8a8e6df2eea300891